Moderna Licensing Arrangements increased by 3019.4% to $967.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19240.0%, from $5.00M to $967.00M. Over 3 years (FY 2022 to FY 2025), Licensing Arrangements shows a downward trend with a -46.5% CAGR.
other_accrued_royalties_current| Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $203.00M | $12.00M | $78.00M | $122.00M | $8.00M | $10.00M | $92.00M | $46.00M | $5.00M | $6.00M | $42.00M | $31.00M | $967.00M |
| QoQ Change | — | -94.1% | +550.0% | +56.4% | -93.4% | +25.0% | +820.0% | -50.0% | -89.1% | +20.0% | +600.0% | -26.2% | >999% |
| YoY Change | — | — | — | -39.9% | — | -16.7% | +17.9% | -62.3% | -37.5% | -40.0% | -54.3% | -32.6% | >999% |